Pharma

Your Article Summary

See Latest Articles

Cel-sci corporation reports third quarter 2009 financial results
CEL-SCI, 08/20/09

CEL–SCI Corporation reports financial results for the three and nine months ended June 30, 2009. The Company's loss from operations for the quarter ended June 2009 was $3.7 million versus a loss of $2.2 million during the same quarter in 2008. Included in the fiscal 2009 third quarter loss of $3.7 million was $2.6 million in non–cash expense. The Company's loss from operations for the nine months ended June 2009 was $8.1 million versus a loss of $7.1 million during the same nine months in 2008.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Abbott Declares 344th Consecutive Quarterly Dividend
Abbott, 12/15/09

Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering
Dendreon Coproration, 12/15/09

Pre-Budget Report response - GSK comments on patent box
GlaxoSmithKline, 12/11/09

 See all of Financial Reports